Netherlands: PAIS [Post-Acute Infection Syndromes] Conference, 26th to 29th August, 2026, Amsterdam

Andy

Senior Member (Voting rights)
Link no longer works. See post #10 for up to date link.


"Join Lionhearted Science – United Against PAIS

Post-Acute Infection Syndromes (PAIS), including Long COVID, are among the most complex and urgent health challenges of our time. Their impact extends far beyond healthcare, affecting work, education, social participation and long-term wellbeing, with growing economic consequences. Despite rapidly growing scientific insight, knowledge remains fragmented across disciplines, countries and care systems. This underscores the need for structured international collaboration to integrate evidence, align clinical practice and accelerate real-world impact.

This is why the World Health Network is organizing the WHN PAIS Conference 2026."

Further details
 
Last edited by a moderator:
It's been highlighted to me that there is a

"Patient Day

On Saturday 29th August, a separate patient afternoon will be organised. Participants of the conference will provide an easy language presentation of their work. More information will follow soon!"

Link

Information elsewhere on the site states that it will be livestreamed but not whether there would be a charge for it or not.
 
Meetings like this are usually organised by companies that make money out of people wanting to 'network' for commercial reasons.

Looking at the World Health Network website it seems an odd rather amateurish looking set-up with bold goals but very little detail. I think it very likely that someone has seen this as a moneyspinner. I have o idea whether or not anybody is likely to attend.
 
Happy to see this on the website:

OUR COMMITMENT TO

HEALTH & SAFETY​

The ISLC-PAIS Conference team are committed to ensuring a safe, inclusive, and science-based environment for all attendees and speakers. We are currently in direct contact with technical partners, to hire / barter Air Disinfection Systems, and have already conducted preliminary assessments at the venue. These assessments indicate that a very high level of air renewal is possible in large parts of the building, which gives us a strong baseline to work from. In addition to ventilation capacity, we are preparing continuous indoor air quality monitoring during the conference using professional CO₂ monitoring units. These systems do not rely on large public displays, but provide real-time readings directly to designated members of the conference team via their mobile devices. Alerts are triggered if thresholds are exceeded, allowing us to immediately coordinate with the venue’s technical staff to adjust ventilation where needed. Regarding personal protective measures, we strongly encourage the use of high-quality masks in all indoor settings to help protect our community and will have a supply of high-quality masks available on site, and hand disinfectant stations will be placed throughout the venue.
 
August 26-29, 2026

Amsterdam (the Netherlands)

ISLC-PAIS Conference

Post-Acute Infection Syndromes (PAIS), including Long COVID, are among the most complex and urgent health challenges of our time. Their impact extends far beyond healthcare, affecting work, education, social participation and long-term wellbeing, with growing economic consequences. Despite rapidly growing scientific insight, knowledge remains fragmented across disciplines, countries and care systems. This underscores the need for structured international collaboration to integrate evidence, align clinical practice and accelerate real-world impact.
This is why we are organizing the ISLC-PAIS Conference 2026 in a COVID-safe environment.
 
The program has been published. Great to see so many familiar faces in Amsterdam. I was however surprised to see the AIR Amygdala Retraining pop up there as well. Claiming to improve fatigue, dysautonomia and inflammatory markers.

 
The program has been published. Great to see so many familiar faces in Amsterdam. I was however surprised to see the AIR Amygdala Retraining pop up there as well. Claiming to improve fatigue, dysautonomia and inflammatory markers.

Wasn’t the preliminary data negative?
 
I think you're talking about the trial that was part of the Long-Covid Project based in Finland:



This study is from Miami:


Ah, thank you for clearing that up.

I see they are using a waitlist control. And they had planned objective measurements. If those are not highlighted in the presentation I think we can be fairly certain they didn’t find anything.
 
Dr Duncan on Bluesky about the new association that launches at the conference in Amsterdam:


Dr Rae Duncan
31. July 2026

Introducing the International Society of Long COVID and Post-Acute Infection Syndromes (ISLC-PAIS)
The COVID-19 Pandemic had highlighted the urgent need for a Paradigm shift in the way we approach post-acute infection syndromes.
ISLC-PAIS aims to answer this call to action islc-pais.com

More research, better medical education & specialist training, Guidelines, CPD, recognition that PAIS is not rare and patients are suffering terribly.
Bringing PAIS into mainstream medicine and working with scientists and patient advocates to help do this.
Just some of the aims and objectives of our new International Society over the coming months and years
Inaugural Society meeting on 13th August for Founding members
Our new International Society will formally launch at our Inaugural ISLC-PAIS International Scientific Conference 26-29th August in Amsterdam, The Netherlands
If you individually or your institution are interested in getting involved please pre-register your interest in becoming a member on our newly launched website.



From their membership page:

Join a society
rewriting what's possible.​

Whether you're a clinician, researcher, or allied health provider, ISLC–PAIS welcomes your voice in advancing care for patients with Long COVID & PAIS.

01 / BENEFITS

Membership is more than access — it's participation in shaping the field.​

01

Knowledge​

Member-exclusive research updates, clinical protocols, and webinars from the working group.

02

Participation​

Eligibility for working committees, study groups, and emerging collaborative projects.

03

Network​

Direct exchange with international experts across Long COVID & PAIS research and care.

04

Access​

Discounted conference registration, continuing education resources, and early-access initiatives.

05

Belonging​

A society rewriting what's possible for complex chronic illness care.


02 / WHO

Who joins ISLC–PAIS​

  • —Physicians, nurses, and allied health professionals
  • —Biomedical, translational, and clinical researchers
  • —Public-health practitioners and policy advisors
  • —Educators training the next clinical generation
  • —Patient advocates with lived-experience expertise

03 / PROCESS

A simple, transparent application path.​

01

Apply​

Submit your application via the form below — including your professional background and motivation.

02

Review​

Our membership committee reviews your application against eligibility criteria.

03

Welcome​

Receive your welcome pack, member ID, and access to exclusive resources and events.


We have a designated ISLC thread here:
 
I saw this on the conference website, listed under satellite events:

ISLC-PAIS website said:
Patient Conference Recap

Online & Onsite
On Saturday 29 August, a Patient Conference Recap will take place, designed specifically for people living with PAIS, including Long COVID.

During this session, selected conference speakers and participants will provide accessible, plain-language summaries of key insights presented during the conference. The aim is to share the most relevant scientific and clinical developments in a format that is meaningful and understandable for patients and their supporters.

This session will be accessible both onsite and via a livestream, with the opportunity for online participants to submit questions during the session. Further details about registration and participation will follow.

Has anyone heard more about this?
 
PAIS...Long Covid...PAIS, they really seem completely determined to never mention ME.

Maybe there is another thread for this discussion, but in general I don't think "PAIS" is a useful category and I have problems to understand why some researchers seem to think otherwise.

Long Covid already often is used as a catch-all that's only defined by the trigger and can mean everything, lung damage, ME, sleep problems whatever. PAIS is even worse, it's neither defined by a specific trigger nor specific symtoms and it's also not mentioned in the ICD, so why are they insisting on using this term?
 
Back
Top Bottom